Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Questions remain over alfacalcidol's efficacy in preventing secondary hyperparathyroidism

letter

. 1995 Jul 8;311(6997):124–125. doi: 10.1136/bmj.311.6997.124b

Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Questions remain over alfacalcidol's efficacy in preventing secondary hyperparathyroidism.

PMCID: PMC2550137 PMID: 7677873

These references are in PubMed. This may not be the complete list of references from this article.

Fournier A., Idrissi A., Sebert J. L., Gueris J., Garabedian M., Renaud H., Westeel P. F. Preventing renal bone disease in moderate renal failure with CaCO3 and 25(OH) vitamin D3. Kidney Int Suppl. 1988 Mar;24:S178–S179. [PubMed] [Google Scholar]
Hamdy N. A., Kanis J. A., Beneton M. N., Brown C. B., Juttmann J. R., Jordans J. G., Josse S., Meyrier A., Lins R. L., Fairey I. T. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995 Feb 11;310(6976):358–363. doi: 10.1136/bmj.310.6976.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
Lafage M. H., Combe C., Fournier A., Aparicio M. Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy. Kidney Int. 1992 Nov;42(5):1217–1225. doi: 10.1038/ki.1992.407. [DOI] [PubMed] [Google Scholar]
Milliner D. S., Zinsmeister A. R., Lieberman E., Landing B. Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int. 1990 Nov;38(5):931–936. doi: 10.1038/ki.1990.293. [DOI] [PubMed] [Google Scholar]